Moreover, hyperglycemia and insulin resistance stimulate systemic inflammation by the release of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) aggravating vascular damage [43, 44]. The gene discussed is IL6; the disease is Hyperglycemia.